
Leap Therapeutics Inc
NASDAQ:LPTX

Fundamental Analysis


Revenue & Expenses Breakdown
Leap Therapeutics Inc
Balance Sheet Decomposition
Leap Therapeutics Inc
Current Assets | 33.9m |
Cash & Short-Term Investments | 32.7m |
Receivables | 711k |
Other Current Assets | 446k |
Non-Current Assets | 1m |
PP&E | 152k |
Other Non-Current Assets | 857k |
Free Cash Flow Analysis
Leap Therapeutics Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Leap Therapeutics Inc
Revenue
|
0
USD
|
Operating Expenses
|
-71.1m
USD
|
Operating Income
|
-71.1m
USD
|
Other Expenses
|
1.7m
USD
|
Net Income
|
-69.4m
USD
|
LPTX Profitability Score
Profitability Due Diligence
Leap Therapeutics Inc's profitability score is 35/100. The higher the profitability score, the more profitable the company is.

Score
Leap Therapeutics Inc's profitability score is 35/100. The higher the profitability score, the more profitable the company is.
LPTX Solvency Score
Solvency Due Diligence
Leap Therapeutics Inc's solvency score is 53/100. The higher the solvency score, the more solvent the company is.

Score
Leap Therapeutics Inc's solvency score is 53/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
LPTX Price Targets Summary
Leap Therapeutics Inc
Dividends
Current shareholder yield for LPTX is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?